182 related articles for article (PubMed ID: 22783262)
1. Mechanisms of T(reg) Suppression: Still a Long Way to Go.
Vignali DA
Front Immunol; 2012; 3():191. PubMed ID: 22783262
[No Abstract] [Full Text] [Related]
2. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance.
Chaturvedi V; Collison LW; Guy CS; Workman CJ; Vignali DA
J Immunol; 2011 Jun; 186(12):6661-6. PubMed ID: 21576509
[TBL] [Abstract][Full Text] [Related]
3. Suppression of mature dendritic cell function by regulatory T cells in vivo is abrogated by CD40 licensing.
Hänig J; Lutz MB
J Immunol; 2008 Feb; 180(3):1405-13. PubMed ID: 18209035
[TBL] [Abstract][Full Text] [Related]
4. Large-scale expansion of rat CD4+ CD25+ T(reg) cells in the absence of T-cell receptor stimulation.
Beyersdorf N; Balbach K; Hünig T; Kerkau T
Immunology; 2006 Dec; 119(4):441-50. PubMed ID: 16903867
[TBL] [Abstract][Full Text] [Related]
5. Prolactin down-regulates CD4+CD25hiCD127low/- regulatory T cell function in humans.
Legorreta-Haquet MV; Chávez-Rueda K; Montoya-Díaz E; Arriaga-Pizano L; Silva-García R; Chávez-Sánchez L; Moreno-Lafont M; Zenteno-Galindo E; Blanco-Favela F
J Mol Endocrinol; 2012 Feb; 48(1):77-85. PubMed ID: 22159143
[TBL] [Abstract][Full Text] [Related]
6. CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs.
Mjösberg J; Berg G; Ernerudh J; Ekerfelt C
Immunology; 2007 Apr; 120(4):456-66. PubMed ID: 17229266
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells.
Sekiya T; Kondo T; Shichita T; Morita R; Ichinose H; Yoshimura A
J Exp Med; 2015 Sep; 212(10):1623-40. PubMed ID: 26304965
[TBL] [Abstract][Full Text] [Related]
8. Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease.
Cai SF; Cao X; Hassan A; Fehniger TA; Ley TJ
Blood; 2010 Mar; 115(9):1669-77. PubMed ID: 19965675
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of T reg-like cells in zebrafish.
Kasheta M; Painter CA; Moore FE; Lobbardi R; Bryll A; Freiman E; Stachura D; Rogers AB; Houvras Y; Langenau DM; Ceol CJ
J Exp Med; 2017 Dec; 214(12):3519-3530. PubMed ID: 29066577
[TBL] [Abstract][Full Text] [Related]
10. Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro.
Buchwald ZS; Kiesel JR; DiPaolo R; Pagadala MS; Aurora R
PLoS One; 2012; 7(6):e38199. PubMed ID: 22701612
[TBL] [Abstract][Full Text] [Related]
11. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.
Bopp T; Becker C; Klein M; Klein-Hessling S; Palmetshofer A; Serfling E; Heib V; Becker M; Kubach J; Schmitt S; Stoll S; Schild H; Staege MS; Stassen M; Jonuleit H; Schmitt E
J Exp Med; 2007 Jun; 204(6):1303-10. PubMed ID: 17502663
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
13. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells.
Roncarolo MG; Gregori S; Levings M
Novartis Found Symp; 2003; 252():115-27; discussion 127-31, 203-10. PubMed ID: 14609215
[TBL] [Abstract][Full Text] [Related]
14. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
[TBL] [Abstract][Full Text] [Related]
15. T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible.
Huang YH; Zozulya AL; Weidenfeller C; Schwab N; Wiendl H
J Leukoc Biol; 2009 Aug; 86(2):273-81. PubMed ID: 19401389
[TBL] [Abstract][Full Text] [Related]
16. Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma.
Chi LJ; Lu HT; Li GL; Wang XM; Su Y; Xu WH; Shen BZ
Clin Exp Immunol; 2010 Sep; 161(3):480-9. PubMed ID: 20646003
[TBL] [Abstract][Full Text] [Related]
17. FOXP3+ regulatory T cells in the human immune system.
Sakaguchi S; Miyara M; Costantino CM; Hafler DA
Nat Rev Immunol; 2010 Jul; 10(7):490-500. PubMed ID: 20559327
[TBL] [Abstract][Full Text] [Related]
18. CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner.
Andersson J; Tran DQ; Pesu M; Davidson TS; Ramsey H; O'Shea JJ; Shevach EM
J Exp Med; 2008 Sep; 205(9):1975-81. PubMed ID: 18710931
[TBL] [Abstract][Full Text] [Related]
19. Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation.
Billiard F; Litvinova E; Saadoun D; Djelti F; Klatzmann D; Cohen JL; Marodon G; Salomon BL
J Immunol; 2006 Aug; 177(4):2167-74. PubMed ID: 16887976
[TBL] [Abstract][Full Text] [Related]
20. Protection against autoimmunity in nonlymphopenic hosts by CD4+ CD25+ regulatory T cells is antigen-specific and requires IL-10 and TGF-beta.
Huang X; Zhu J; Yang Y
J Immunol; 2005 Oct; 175(7):4283-91. PubMed ID: 16177068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
